Sound Pharma Announces Positive Phase 3 Results for the Treatment of Meniere’s Disease with SPI-1005
SEATTLE--(BUSINESS WIRE)--Sound Pharmaceuticals is pleased to announce that the pivotal Phase 3 clinical trial involving SPI-1005, a novel anti-inflammatory compound (ebselen), for the treatment of ...
Electric vehicle engines are almost silent. They’re so quiet, automakers have to add sounds to warn pedestrians and cyclists that EVs are approaching. To avoid collisions, the National Highway Traffic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results